However, stratification of ccRCC samples according to tumor grade revealed that global YBX3/ZONAB/CSDA expression level is higher in the low-grade tumors and lower in the high-grade tumors. This evidence concerns the gene YBX3 and nonpapillary renal cell carcinoma.